Neuropathix Inc. Asset Turnover Ratio (TYGS), as of first quarter 2022, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Neuropathix Inc.  (TYGS)
 

Neuropathix Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Neuropathix Inc. asset turnover ratio, the ability of Neuropathix Inc.'s assets to generate revenue in the first quarter 2022, increased sequentially to 1.56 in the first quarter (Mar 31 2022), TYGS's balance sheet remain strong.

Within sector Neuropathix Inc. achieved the highest asset turnover ratio. While asset turnover ranking remained unchanged in the First Quarter 2022 compared to previous quarter at no. .

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TYGS Asset Turnover Ratio (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter		 (Mar 31 2021)
I. Quarter
Y / Y Asset Change -24.73 % -13.46 % -56.72 % -32 % 145.69 %
Y / Y Revenue Change 549.94 % - - - -
Asset Turnover Ratio (TTM) 1.56 0.7 0.25 - 0.09
TYGS's Total Ranking # # # # #
Seq. Asset Change 72.4 % 50.38 % -6.99 % -68.78 % 98.2 %
Seq. Revenue Change 78.56 % 232.79 % - - -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0 0 0
 




TYGS Company Profile • Back to TYGS Efficiency Comparisons • Compare TYGS Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2022, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2022 Assets at quarter ending Mar 31 2022
Patterson Companies Inc   2.31 $ 6,499.405  Millions$ 2,814.675  Millions
Integrated Biopharma Inc  2.30 $ 60.037  Millions$ 26.136  Millions
Healthcare Services Group Inc   2.12 $ 1,661.019  Millions$ 783.911  Millions
Escalon Medical Corp   1.95 $ 10.627  Millions$ 5.460  Millions
Nature s Sunshine Products inc   1.86 $ 452.157  Millions$ 242.620  Millions
Cadre Holdings inc   1.74 $ 421.158  Millions$ 241.625  Millions
H cyte Inc  1.72 $ 1.615  Millions$ 0.936  Millions
Kewaunee Scientific Corporation  1.72 $ 168.872  Millions$ 98.187  Millions
Allied Healthcare Products inc   1.68 $ 28.050  Millions$ 16.712  Millions
Champions Oncology Inc   1.63 $ 49.109  Millions$ 30.093  Millions
Privia Health Group Inc   1.62 $ 1,066.414  Millions$ 659.689  Millions
Chemed Corporation  1.61 $ 2,152.820  Millions$ 1,337.602  Millions
Vaso Corporation  1.57 $ 76.069  Millions$ 48.545  Millions
Progyny Inc   1.55 $ 550.705  Millions$ 355.587  Millions
Scienture Holdings Inc   1.53 $ 9.172  Millions$ 6.004  Millions
Henry Schein Inc   1.51 $ 12,655.060  Millions$ 8,368.227  Millions
Star Equity Holdings Inc   1.46 $ 109.254  Millions$ 74.879  Millions
Sunlink Health Systems Inc   1.46 $ 45.540  Millions$ 31.268  Millions
International Stem Cell Corporation  1.44 $ 7.538  Millions$ 5.249  Millions
Encision Inc   1.43 $ 7.669  Millions$ 5.359  Millions
Vycor Medical Inc   1.42 $ 1.411  Millions$ 0.993  Millions
Mimedx Group Inc   1.41 $ 257.542  Millions$ 182.510  Millions
Bionexus Gene Lab Corp   1.36 $ 12.942  Millions$ 9.491  Millions
Skinhealth Systems Inc   1.34 $ 335.416  Millions$ 249.469  Millions
Idexx Laboratories Inc  1.33 $ 3,274.202  Millions$ 2,456.946  Millions
Prophase Labs Inc   1.32 $ 111.302  Millions$ 84.478  Millions
Vir Biotechnology Inc   1.31 $ 2,325.898  Millions$ 1,777.298  Millions
Reflect Scientific Inc  1.30 $ 3.006  Millions$ 2.319  Millions
Innovage Holding Corp   1.29 $ 697.395  Millions$ 541.142  Millions
Option Care Health Inc   1.29 $ 3,595.187  Millions$ 2,793.524  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.